Pathophysiology of pulmonary hypertension in acute lung injury.
暂无分享,去创建一个
M. Griffiths | D. McAuley | L. Price | S. Wort | S. Finney | P. Marino
[1] Horst Olschewski,et al. Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[2] B. Thompson,et al. Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance* , 2012, Critical care medicine.
[3] J. Granton,et al. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. , 2011, American journal of respiratory and critical care medicine.
[4] A. Rahmouni,et al. Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. , 2011, American journal of respiratory and critical care medicine.
[5] E. Foster,et al. Clinical significance of elevated B-type natriuretic peptide in patients with acute lung injury with or without right ventricular dilatation: an observational cohort study , 2011, Annals of intensive care.
[6] D. Talmor,et al. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. , 2011, Chest.
[7] M. Moss,et al. Pulmonary vascular dysfunction is associated with poor outcomes in patients with acute lung injury. , 2010, American journal of respiratory and critical care medicine.
[8] J. Wetterslev,et al. Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). , 2010, The Cochrane database of systematic reviews.
[9] E. Swart,et al. Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS , 2009, Intensive Care Medicine.
[10] M. Matthay,et al. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. , 2009, The Journal of clinical investigation.
[11] L. Brochard,et al. Impact of acute hypercapnia and augmented positive end-expiratory pressure on right ventricle function in severe acute respiratory distress syndrome , 2009, Intensive Care Medicine.
[12] I. Adcock,et al. Synergistic Induction of Endothelin-1 by Tumor Necrosis Factor α and Interferon γ Is due to Enhanced NF-κB Binding and Histone Acetylation at Specific κB Sites , 2009, The Journal of Biological Chemistry.
[13] P. Frenette,et al. HETEROTYPIC INTERACTIONS ENABLED BY POLARIZED NEUTROPHIL MICRODOMAINS MEDIATE THROMBO-INFLAMMATORY INJURY , 2009, Nature Medicine.
[14] E. Mark,et al. Interleukin-6 Overexpression Induces Pulmonary Hypertension , 2009, Circulation research.
[15] M. Siegel,et al. Randomized clinical trial of activated protein C for the treatment of acute lung injury. , 2008, American journal of respiratory and critical care medicine.
[16] E. Chilvers,et al. Advances in neutrophil biology: clinical implications. , 2008, Chest.
[17] R. Chambers. Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? , 2008, British journal of pharmacology.
[18] N. Maniatis,et al. The endothelium in acute lung injury/acute respiratory distress syndrome , 2008, Current opinion in critical care.
[19] N. Anguel,et al. Incidence and prognostic value of right ventricular failure in acute respiratory distress syndrome , 2008, Intensive Care Medicine.
[20] A. Arner,et al. Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction , 2008, Intensive Care Medicine.
[21] E. Foster,et al. Pulmonary dead space fraction and pulmonary artery systolic pressure as early predictors of clinical outcome in acute lung injury. , 2007, Chest.
[22] M. Cybulsky,et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.
[23] G. Bernard,et al. Acute lung injury and the acute respiratory distress syndrome: a clinical review , 2007, The Lancet.
[24] Hsueh-Wen Chang,et al. The Initial Response to Inhaled Nitric Oxide Treatment for Intensive Care Unit Patients with Acute Respiratory Distress Syndrome , 2007, Respiration.
[25] John T Granton,et al. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.
[26] T. Geiser,et al. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor , 2007, Thorax.
[27] G. Iapichino,et al. Vardenafil and Weaning from Inhaled Nitric Oxide: Effect on Pulmonary Hypertension in ARDS , 2007, Anaesthesia and intensive care.
[28] F. Jardin,et al. Is there a safe plateau pressure in ARDS? The right heart only knows , 2007, Intensive Care Medicine.
[29] K. Ley,et al. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. , 2006, The Journal of clinical investigation.
[30] R. Homer,et al. Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell death , 2006, Nature Medicine.
[31] C. Ricachinevsky,et al. Treatment of pulmonary arterial hypertension. , 2006, Jornal de pediatria.
[32] B. Culver,et al. Respiratory Physiology: The Essentials, 7th edition. , 2006 .
[33] R. Kondo,et al. Neutrophil cytoskeletal rearrangements during capillary sequestration in bacterial pneumonia in rats. , 2006, American journal of respiratory and critical care medicine.
[34] A. De Gaetano,et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study* , 2006, Critical care medicine.
[35] M. Matthay,et al. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. , 2006, The Journal of clinical investigation.
[36] A. Malik,et al. Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.
[37] T. Evans,et al. Inhaled nitric oxide therapy in adults. , 2005, The New England journal of medicine.
[38] M. Singer,et al. Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil? , 2005, British journal of anaesthesia.
[39] E. Swenson,et al. Physiological aspects of high-altitude pulmonary edema. , 2005, Journal of applied physiology.
[40] M. Matthay,et al. Differential effects of sustained inflation recruitment maneuvers on alveolar epithelial and lung endothelial injury* , 2005, Critical care medicine.
[41] C. Hanson,et al. Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution , 1994, Intensive Care Medicine.
[42] C. Hanson,et al. Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution , 1994, Intensive Care Medicine.
[43] P. Radermacher,et al. Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS , 2005, Intensive Care Medicine.
[44] P. Parsons,et al. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. , 2004, American journal of respiratory and critical care medicine.
[45] L. Shekerdemian,et al. Endothelin-A Receptor Blockade and Inhaled Nitric Oxide in a Porcine Model of Meconium Aspiration Syndrome , 2004, Pediatric Research.
[46] C. Roussos,et al. Pulmonary endothelium in acute lung injury: from basic science to the critically ill , 2004, Intensive Care Medicine.
[47] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[48] M. Matthay,et al. Plasma protein C levels in patients with acute lung injury: Prognostic significance , 2004, Critical care medicine.
[49] Robert W. Taylor,et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. , 2004, JAMA.
[50] A. Goetz,et al. Platelet-endothelial cell interaction in pulmonary microcirculation: the role of PARS , 2004, Thrombosis and Haemostasis.
[51] M. Matthay,et al. Protein C and thrombomodulin in human acute lung injury. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[52] C. Mélot,et al. Endothelin receptor blockade in canine oleic acid-induced lung injury , 2003, Intensive Care Medicine.
[53] R. Rossaint,et al. Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. , 2003, American journal of respiratory and critical care medicine.
[54] Chadi I. Yaacoub,et al. Alarming hypoxemia during one-lung ventilation in a patient with respiratory bronchiolitis-associated interstitial lung disease , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[55] E. Russi,et al. Long-term assessment of lung function in survivors of severe ARDS. , 2003, Chest.
[56] O. Kemmotsu,et al. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. , 2003, Thrombosis research.
[57] W. Seeger,et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial , 2002, The Lancet.
[58] T. van der Poll,et al. Endothelium: Interface between coagulation and inflammation , 2002, Critical care medicine.
[59] R. Naeije,et al. Importance of hypoxic vasoconstriction in maintaining oxygenation during acute lung injury , 2002, Critical care medicine.
[60] Rian,et al. PULMONARY DEAD-SPACE FRACTION AS A RISK FACTOR FOR DEATH IN THE ACUTE RESPIRATORY DISTRESS SYNDROME , 2002 .
[61] S. Dudek,et al. Cytoskeletal regulation of pulmonary vascular permeability. , 2001, Journal of applied physiology.
[62] F. Jardin,et al. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: Incidence, clinical implications, and prognosis , 2001, Critical care medicine.
[63] C. Sartori,et al. High-Altitude Pulmonary Edema Is Initially Caused by an Increase in Capillary Pressure , 2001, Circulation.
[64] T. Evans,et al. Influence of direct and indirect etiology on acute outcome and 6-month functional recovery in acute respiratory distress syndrome. , 2001, Critical care medicine.
[65] J. West. Invited review: pulmonary capillary stress failure. , 2000, Journal of applied physiology.
[66] U. Dafni,et al. Pulmonary Capillary Endothelium-Bound Angiotensin-Converting Enzyme Activity in Acute Lung Injury , 2000, Circulation.
[67] M. Tsokos,et al. Immunohistochemical expression of E-selectin in sepsis-induced lung injury , 2000, International Journal of Legal Medicine.
[68] R. McIntyre,et al. Thirty years of clinical trials in acute respiratory distress syndrome , 2000, Critical care medicine.
[69] J. Tomashefski. Pulmonary pathology of acute respiratory distress syndrome. , 2000, Clinics in chest medicine.
[70] A. Bindels,et al. Right ventricular failure in acute respiratory distress syndrome. , 2000, The Netherlands journal of medicine.
[71] P. V. Ichinsky,et al. Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease , 2000 .
[72] P. V. van Heerden,et al. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. , 2000, Chest.
[73] E. Vichinsky,et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. , 2000, The New England journal of medicine.
[74] L. McIntire,et al. Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells. , 2000, Blood.
[75] W. Hurford,et al. Inhaled nitric oxide: basic biology and clinical applications. , 1999, Anesthesiology.
[76] Ju-Yi Chen,et al. Effect of Meconium Aspiration on Plasma Endothelin-1 Level and Pulmonary Hemodynamics in a Piglet Model , 1999, Neonatology.
[77] W. Kuebler,et al. Pressure is proinflammatory in lung venular capillaries. , 1999, The Journal of clinical investigation.
[78] R. Rossaint,et al. Combination of inhaled nitric oxide and intravenous prostacyclin for successful treatment of severe pulmonary hypertension in a patient with acute respiratory distress syndrome , 1999, Intensive Care Medicine.
[79] D. Schuster,et al. Response to inhaled nitric oxide in acute lung injury depends on distribution of pulmonary blood flow prior to its administration. , 1999, American journal of respiratory and critical care medicine.
[80] Wort Sj,et al. The role of the endothelium in modulating vascular control in sepsis and related conditions. , 1999 .
[81] T. Evans,et al. The role of the endothelium in modulating vascular control in sepsis and related conditions. , 1999, British medical bulletin.
[82] A. Pohlman,et al. Response to inhaled nitric oxide in patients with acute right heart syndrome. , 1999, American journal of respiratory and critical care medicine.
[83] J. Zimmerman,et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. , 1998, Critical care medicine.
[84] D. Hansell,et al. Clinical correlates in acute lung injury: response to inhaled nitric oxide. , 1998, Chest.
[85] J. Carlet,et al. Hemodynamic profile in severe ARDS: results of the European Collaborative ARDS Study , 1998, Intensive Care Medicine.
[86] J. Dhainaut,et al. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. , 1998, American journal of respiratory and critical care medicine.
[87] K. Domino,et al. Effects of posture on blood flow diversion by hypoxic pulmonary vasoconstriction in dogs. , 1998, British journal of anaesthesia.
[88] L. Berggren,et al. Pulmonary function in adult survivors of severe acute lung injury treated with inhaled nitric oxide , 1998, Acta anaesthesiologica Scandinavica.
[89] M. Booke,et al. Inhaled Prostaglandin E1 for Treatment of Acute Lung Injury in Severe Multiple Organ Failure , 1998, Anesthesia and analgesia.
[90] T. Evans,et al. Comparison of nose and face mask CPAP therapy for sleep apnoea , 1998, Thorax.
[91] T. Evans,et al. Measurement of endogenous nitric oxide in the lungs of patients with the acute respiratory distress syndrome. , 1998, American journal of respiratory and critical care medicine.
[92] M. Uchiba,et al. Antithrombin III (AT III) Prevents LPS-Induced Pulmonary Vascular Injury: Novel Biological Activity of AT III , 1997, Seminars in thrombosis and hemostasis.
[93] K. Geiger,et al. Large increase in cardiac output in a patient with ARDS and acute right heart failure during inhalation of nitric oxide , 1997, Acta anaesthesiologica Scandinavica.
[94] J. T. Owings,et al. Acquired antithrombin deficiency following severe traumatic injury: rationale for study of antithrombin supplementation. , 1997, Seminars in thrombosis and hemostasis.
[95] J. Harenberg,et al. Monoclonal Antibodies against Heparin and Heparinoids , 1997, Seminars in thrombosis and hemostasis.
[96] K. Takatsuki,et al. Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation. , 1997, The American journal of physiology.
[97] M. Haller,et al. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.
[98] R. Naeije,et al. Effects of hypoxic pulmonary vasoconstriction on pulmonary gas exchange. , 1996, Journal of applied physiology.
[99] H. Isobe,et al. RECOMBINANT THROMBOMODULIN PREVENTS ENDOTOXIN‐INDUCED LUNG INJURY IN RATS BY INHIBITING LEUKOCYTE ACTIVATION: 227 , 1996 .
[100] R. Shenkar,et al. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. , 1996, Critical care medicine.
[101] R. McIntyre,et al. Impact of respiratory acid-base status in patients with pulmonary hypertension. , 1996, The Annals of thoracic surgery.
[102] D. Faller,et al. Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture. , 1995, The Journal of clinical investigation.
[103] A Giaid,et al. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.
[104] J. Dhainaut,et al. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. , 1995, American journal of respiratory and critical care medicine.
[105] P. Barnes,et al. Regulation of pulmonary vascular tone. , 1995, Pharmacological reviews.
[106] T. Dahms,et al. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. , 1995, American journal of respiratory and critical care medicine.
[107] T. Evans,et al. In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery. , 1995, The American journal of physiology.
[108] R. Strieter,et al. Acute lung injury: the role of cytokines in the elicitation of neutrophils. , 1994, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[109] T. Evans,et al. Pulmonary endothelial permeability in patients with severe lung injury. Clinical correlates and natural history. , 1994, Chest.
[110] J. Stamler,et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. , 1994, Circulation.
[111] R. Kacmarek,et al. Prolonged Inhalation of Low Concentrations of Nitric Oxide in Patients with Severe Adult Respiratory Distress Syndrome: Effects on Pulmonary Hemodynamics and Oxygenation , 1994, Anesthesiology.
[112] B. Freeman. Free radical chemistry of nitric oxide. Looking at the dark side. , 1994, Chest.
[113] H. Adams,et al. EFFECTS OF CYTOKINES TUMOR NECROSIS FACTOR α AND INTERLEUKIN 1β ON ENDOTOXIN‐MEDIATED INHIBITION OF ENDOTHELIUM‐DERIVED RELAXING FACTOR BIOACTIVITY AND NITRIC OXIDE PRODUCTION IN VASCULAR ENDOTHELIUM , 1994, Shock.
[114] D. Laporta,et al. Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. , 1993, The American review of respiratory disease.
[115] K. Lenz,et al. Endothelin-1 in adult respiratory distress syndrome. , 1993, The American review of respiratory disease.
[116] W. Seeger,et al. Aerosolised prostacyclin in adult respiratory distress syndrome , 1993, The Lancet.
[117] J. Hogg,et al. Comparison of neutrophil and capillary diameters and their relation to neutrophil sequestration in the lung. , 1993, Journal of applied physiology.
[118] M. Blaustein,et al. Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. , 1993, The American journal of physiology.
[119] T. Hurst,et al. Insufflated halothane increases venous admixture less than nitroprusside in canine atelectasis. , 1992, Anesthesiology.
[120] R. Sánchez,et al. Comparative study between the effects of total intravenous anesthesia with propofol and balanced anesthesia with halothane on the alveolar-arterial oxygen tension difference and on the pulmonary shunt. , 1992, Archives of medical research.
[121] G. Bernard,et al. Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. , 1991, The American review of respiratory disease.
[122] A. Redington,et al. Doppler echocardiographic evaluation of pulmonary blood flow after the Fontan operation: the role of the lungs. , 1991, British heart journal.
[123] D. Crawley,et al. Endogenous nitric oxide modulates adrenergic neural vasoconstriction in guinea‐pig pulmonary artery , 1991, British journal of pharmacology.
[124] T. Martin,et al. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. , 1991, The American journal of physiology.
[125] C. Mélot,et al. PEEP inhibits hypoxic pulmonary vasoconstriction in dogs. , 1991, Journal of applied physiology.
[126] D. Green,et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. , 1990, The Journal of clinical investigation.
[127] C. Mélot,et al. Inhibition of hypoxic pulmonary vasoconstriction by increased left atrial pressure in dogs. , 1990, The American journal of physiology.
[128] F. Lemaire,et al. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. , 1990, The New England journal of medicine.
[129] C. Mélot,et al. Effects of acidosis and alkalosis on hypoxic pulmonary vasoconstriction in dogs. , 1990, The American journal of physiology.
[130] J. Sadler,et al. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. , 1989, The Journal of biological chemistry.
[131] L. Bjertnaes,et al. Interaction of verapamil and halogenated inhalation anesthetics on hypoxic pulmonary vasoconstriction. , 1989, Acta anaesthesiologica Scandinavica.
[132] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.
[133] W. Zapol,et al. Pulmonary vascular obstruction in severe ARDS: angiographic alterations after i.v. fibrinolytic therapy. , 1987, AJR. American journal of roentgenology.
[134] C. Francis,et al. Fibrin induces release of von Willebrand factor from endothelial cells. , 1987, The Journal of clinical investigation.
[135] C. N. Gillis,et al. Depressed prostaglandin E1 and 5-hydroxytryptamine removal in patients with adult respiratory distress syndrome. , 1986, The American review of respiratory disease.
[136] B. Meyrick,et al. Repeated Escherichia coli endotoxin-induced pulmonary inflammation causes chronic pulmonary hypertension in sheep. Structural and functional changes. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[137] K. Kubo,et al. [Hypoxic pulmonary vasoconstriction]. , 1985, Kokyu to junkan. Respiration & circulation.
[138] P. Guéret,et al. Two‐dimensional echocardiographic evaluation of right ventricular size and contractility in acute respiratory failure , 1985, Critical care medicine.
[139] J. Tomashefski,et al. The pulmonary vascular lesions of the adult respiratory distress syndrome. , 1983, The American journal of pathology.
[140] W. Sibbald,et al. Pulmonary accumulation of polymorphonuclear leukocytes in the adult respiratory distress syndrome , 1982, Critical care medicine.
[141] W. Zapol,et al. Pulmonary vascular remodeling in adult respiratory distress syndrome. , 1982, The American review of respiratory disease.
[142] W. Zapol,et al. Acute Pulmonary Hypertension and Lung Thromboxane Release after Endotoxin Infusion in Normal and Leukopenic Sheep , 1982, Circulation research.
[143] S. Oparil,et al. Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: A preliminary report , 1981, Critical care medicine.
[144] A. Morris,et al. Pulmonary function and exercise gas exchange in survivors of adult respiratory distress syndrome. , 1981, The American review of respiratory disease.
[145] H. Redl,et al. Electron-microscopic investigation of lung biopsies in patients with post-traumatic respiratory insufficiency. , 1980, Acta chirurgica Scandinavica. Supplementum.
[146] W. Zapol,et al. Pulmonary hypertension in severe acute respiratory failure. , 1977, The New England journal of medicine.
[147] J. Benumof,et al. Dependency of hypoxic pulmonary vasoconstriction on temperature. , 1977, Journal of applied physiology: respiratory, environmental and exercise physiology.
[148] R. Bone,et al. Intravascular coagulation associated with the adult respiratory distress syndrome. , 1976, The American journal of medicine.
[149] John F. Nunn,et al. Respiratory Physiology—the essentials , 1975 .
[150] J. Reeves,et al. Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis. , 1972, The Journal of clinical investigation.
[151] T L Petty,et al. Acute respiratory distress in adults. , 1967, Lancet.
[152] T. Saldeen. BLOOD COAGULATION AND SHOCK. , 1979, British medical journal.
[153] D. Shelton,et al. Vascular Obstruction Causes Pulmonary Hypertension in Severe Acute Respiratory Failure , 2022 .